Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$4.59 - $8.96 $86,292 - $168,448
-18,800 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$2.65 - $6.08 $49,820 - $114,304
18,800 New
18,800 $71,000
Q2 2019

Aug 12, 2019

SELL
$3.06 - $51.61 $29,070 - $490,295
-9,500 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$31.16 - $48.62 $296,020 - $461,890
9,500 New
9,500 $359,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $72.5M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.